Allan Gobbs
CEO, Managing Partner · ATEM Capital Fund LP
Allan Gobbs, Co-Founder and Managing Partner of ATEM Capital, primarily invests in **late-stage biopharma** companies with proven human proof of concept, allocating roughly 50% of the fund to this sector while also investing 20% in early-stage biopharma and 30% in **digital health**[2][4]. His distinctive thesis favors a **conservative strategy** targeting assets with established clinical data, a…
- Stages: Pre-Seed, Seed, Series A
- Focus: AI
- Location: New York, New York, United States
LinkedIn
Website
Browse all investors · Browse founders